156 related articles for article (PubMed ID: 25388527)
21. Gene expression profiling of progressive papillary noninvasive carcinomas of the urinary bladder.
Wild PJ; Herr A; Wissmann C; Stoehr R; Rosenthal A; Zaak D; Simon R; Knuechel R; Pilarsky C; Hartmann A
Clin Cancer Res; 2005 Jun; 11(12):4415-29. PubMed ID: 15958626
[TBL] [Abstract][Full Text] [Related]
22. Molecular alterations associated with bladder cancer initiation and progression.
Cordon-Cardo C
Scand J Urol Nephrol Suppl; 2008 Sep; (218):154-65. PubMed ID: 18815930
[TBL] [Abstract][Full Text] [Related]
23. Searching for urine biomarkers of bladder cancer recurrence using a liquid chromatography-mass spectrometry and capillary electrophoresis-mass spectrometry metabolomics approach.
Alberice JV; Amaral AF; Armitage EG; Lorente JA; Algaba F; Carrilho E; Márquez M; García A; Malats N; Barbas C
J Chromatogr A; 2013 Nov; 1318():163-70. PubMed ID: 24139504
[TBL] [Abstract][Full Text] [Related]
24. Urinary metabonomic study on colorectal cancer.
Qiu Y; Cai G; Su M; Chen T; Liu Y; Xu Y; Ni Y; Zhao A; Cai S; Xu LX; Jia W
J Proteome Res; 2010 Mar; 9(3):1627-34. PubMed ID: 20121166
[TBL] [Abstract][Full Text] [Related]
25. Metabonomic profiling of diet-induced hyperlipidaemia in a rat model.
Zhang Q; Wang G; A J; Ma B; Dua Y; Zhu L; Wu D
Biomarkers; 2010 May; 15(3):205-16. PubMed ID: 20001218
[TBL] [Abstract][Full Text] [Related]
26. Use of urinary biomarkers for bladder cancer surveillance: patient perspectives.
Yossepowitch O; Herr HW; Donat SM
J Urol; 2007 Apr; 177(4):1277-82; discussion 1282. PubMed ID: 17382711
[TBL] [Abstract][Full Text] [Related]
27. [Bladder cancer biomarkers].
Dobrowolska-Glazar B; Glazar W; Dobrowolski Z; Lipczyński W
Przegl Lek; 2010; 67(7):479-83. PubMed ID: 21387760
[TBL] [Abstract][Full Text] [Related]
28. Metabonomic analysis of HIV-infected biofluids.
Sitole LJ; Williams AA; Meyer D
Mol Biosyst; 2013 Jan; 9(1):18-28. PubMed ID: 23114495
[TBL] [Abstract][Full Text] [Related]
29. Recent advances in bladder cancer diagnostics.
Sanchez-Carbayo M
Clin Biochem; 2004 Jul; 37(7):562-71. PubMed ID: 15234237
[TBL] [Abstract][Full Text] [Related]
30. Noninvasive approaches for detecting and monitoring bladder cancer.
Talukdar S; Emdad L; Das SK; Sarkar D; Fisher PB
Expert Rev Anticancer Ther; 2015 Mar; 15(3):283-94. PubMed ID: 25494295
[TBL] [Abstract][Full Text] [Related]
31. Urine markers for detection and surveillance of bladder cancer.
Xylinas E; Kluth LA; Rieken M; Karakiewicz PI; Lotan Y; Shariat SF
Urol Oncol; 2014 Apr; 32(3):222-9. PubMed ID: 24054865
[TBL] [Abstract][Full Text] [Related]
32. Direct infusion mass spectrometry or liquid chromatography mass spectrometry for human metabonomics? A serum metabonomic study of kidney cancer.
Lin L; Yu Q; Yan X; Hang W; Zheng J; Xing J; Huang B
Analyst; 2010 Nov; 135(11):2970-8. PubMed ID: 20856980
[TBL] [Abstract][Full Text] [Related]
33. Urinary biomarkers of bladder cancer: an update and future perspectives.
Rosser CJ; Urquidi V; Goodison S
Biomark Med; 2013 Oct; 7(5):779-90. PubMed ID: 24044570
[TBL] [Abstract][Full Text] [Related]
34. Reliability of MR imaging-based virtual cystoscopy in the diagnosis of cancer of the urinary bladder.
Lämmle M; Beer A; Settles M; Hannig C; Schwaibold H; Drews C
AJR Am J Roentgenol; 2002 Jun; 178(6):1483-8. PubMed ID: 12034625
[TBL] [Abstract][Full Text] [Related]
35. Potential of urinary biomarkers in early bladder cancer diagnosis.
Lam T; Nabi G
Expert Rev Anticancer Ther; 2007 Aug; 7(8):1105-15. PubMed ID: 18028019
[TBL] [Abstract][Full Text] [Related]
36. NMP-22, urinary cytology, and cystoscopy: a 1 year comparison study.
Schlake A; Crispen PL; Cap AP; Atkinson T; Davenport D; Preston DM
Can J Urol; 2012 Aug; 19(4):6345-50. PubMed ID: 22892257
[TBL] [Abstract][Full Text] [Related]
37. Pathological possibilities and pitfalls in detecting aggressive bladder cancer.
Mitra AP; Jordà M; Cote RJ
Curr Opin Urol; 2012 Sep; 22(5):397-404. PubMed ID: 22825461
[TBL] [Abstract][Full Text] [Related]
38. Novel endoscopic diagnosis for bladder cancer.
Lerner SP; Goh A
Cancer; 2015 Jan; 121(2):169-78. PubMed ID: 25132313
[TBL] [Abstract][Full Text] [Related]
39. [Study on specific metabonomic profiling of serum from colorectal cancer patients by gas chromatography-mass spectrometry].
Ma YL; Liu WJ; Peng JY; Zhang P; Chen HQ; Qin HL
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Jul; 12(4):386-90. PubMed ID: 19598026
[TBL] [Abstract][Full Text] [Related]
40. Discovery of Apo-A1 as a potential bladder cancer biomarker by urine proteomics and analysis.
Li C; Li H; Zhang T; Li J; Liu L; Chang J
Biochem Biophys Res Commun; 2014 Apr; 446(4):1047-52. PubMed ID: 24661883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
